Aptose Biosciences Inc.
TSX:APS
C$ 1.58
C$-0.10 (-5.95%)
C$ 1.58
C$-0.10 (-5.95%)
End-of-day quote: 05/13/2024

APS: Global investment alternatives & competitors

Competitors

Ticker Price Forecast 1Y Forecast 2Y Market Cap Div Yld Growth Rate
NasdaqGM:XENE
Xenon Pharmaceuticals
40.48 0% 0% 3,206.44 0% 0%
NasdaqGM:AUPH
Aurinia Pharmaceuticals
5.02 0% 0% 727.58 0% 0%
NasdaqGS:ZYME
Zymeworks
9.24 0% 0% 655.73 0% -,190.53%
NasdaqCM:EPIX
ESSA Pharma
5.93 0% 0% 262.33 0% 0%
OTCPK:ACHF.F
Arch Biopartners
1.12 0% 0% 164.13 0% 0%
TSX:CRDL
Cardiol Therapeutics
3.01 0% 0% 168.66 0% 0%
NasdaqGS:MIST
Milestone Pharmaceuticals
1.70 0% 0% 106.64 0% 0%
TSX:SVA
Sernova
0.35 0% 0% 136.53 0% 0%
TSX:MDNA
Medicenna Therapeutics
2.46 0% 0% 73.12 0% 0%
NasdaqCM:PMN
ProMIS Neurosciences
2.00 0% 0% 37.92 0% 0%
TSX:BCT
BriaCell Therapeutics
2.99 0% 0% 45.71 0% 0%
NasdaqGM:IPA
ImmunoPrecise Antibodies
1.26 0% 0% 33.16 0% 0%
TSX:MBX
Microbix Biosystems
0.43 0% 0% 38.92 0% 0%
TSXV:IBT
IBEX Technologies
1.44 0% 0% 35.3 0% 0%
OTCPK:TBPM.Q
Tetra Bio-Pharma
0.00 0% 0% 21.17 0% 0%
TSX:BU
Burcon NutraScience
0.26 0% 0% 28.42 0% 0%
TSXV:COV
Covalon Technologies
1.01 0% 0% 23.93 0% 78.32%
DB:20B
Biomark Diagnostics
0.14 0% 0% 15.81 0% 0%
TSXV:SBM
Sirona Biochem
0.06 0% 0% 20.32 0% 0%
NasdaqCM:EDSA
Edesa Biotech
4.44 0% 0% 14.83 0% 0%